These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 25051497)

  • 1. Noncoding RNAs in vascular inflammation and atherosclerosis: recent advances toward therapeutic applications.
    Cochain C; Zernecke A
    Curr Opin Lipidol; 2014 Oct; 25(5):380-6. PubMed ID: 25051497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-coding RNA regulation of endothelial and macrophage functions during atherosclerosis.
    Aryal B; Suárez Y
    Vascul Pharmacol; 2019 Mar; 114():64-75. PubMed ID: 29551552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-coding RNAs in cardiovascular cell biology and atherosclerosis.
    Fasolo F; Di Gregoli K; Maegdefessel L; Johnson JL
    Cardiovasc Res; 2019 Oct; 115(12):1732-1756. PubMed ID: 31389987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noncoding RNAs and atherosclerosis.
    Aryal B; Rotllan N; Fernández-Hernando C
    Curr Atheroscler Rep; 2014 May; 16(5):407. PubMed ID: 24623179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-126, -145, and -155: a therapeutic triad in atherosclerosis?
    Wei Y; Nazari-Jahantigh M; Neth P; Weber C; Schober A
    Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):449-54. PubMed ID: 23324496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noncoding RNAs in atherosclerosis: regulation and therapeutic potential.
    Qi L; Xing J; Yuan Y; Lei M
    Mol Cell Biochem; 2024 May; 479(5):1279-1295. PubMed ID: 37418054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of microRNA-92a prevents endothelial dysfunction and atherosclerosis in mice.
    Loyer X; Potteaux S; Vion AC; Guérin CL; Boulkroun S; Rautou PE; Ramkhelawon B; Esposito B; Dalloz M; Paul JL; Julia P; Maccario J; Boulanger CM; Mallat Z; Tedgui A
    Circ Res; 2014 Jan; 114(3):434-43. PubMed ID: 24255059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RP5-833A20.1/miR-382-5p/NFIA-dependent signal transduction pathway contributes to the regulation of cholesterol homeostasis and inflammatory reaction.
    Hu YW; Zhao JY; Li SF; Huang JL; Qiu YR; Ma X; Wu SG; Chen ZP; Hu YR; Yang JY; Wang YC; Gao JJ; Sha YH; Zheng L; Wang Q
    Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):87-101. PubMed ID: 25265644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-155 in the pathogenesis of atherosclerosis: a conflicting role?
    Ma X; Ma C; Zheng X
    Heart Lung Circ; 2013 Oct; 22(10):811-8. PubMed ID: 23827206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of endothelial cell-derived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression.
    Horio E; Kadomatsu T; Miyata K; Arai Y; Hosokawa K; Doi Y; Ninomiya T; Horiguchi H; Endo M; Tabata M; Tazume H; Tian Z; Takahashi O; Terada K; Takeya M; Hao H; Hirose N; Minami T; Suda T; Kiyohara Y; Ogawa H; Kaikita K; Oike Y
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):790-800. PubMed ID: 24526691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long Noncoding RNA: Recent Updates in Atherosclerosis.
    Li H; Zhu H; Ge J
    Int J Biol Sci; 2016; 12(7):898-910. PubMed ID: 27314829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosomal non-coding RNAs: Emerging therapeutic targets in atherosclerosis.
    Alidadi M; Hjazi A; Ahmad I; Mahmoudi R; Sarrafha M; Reza Hosseini-Fard S; Ebrahimzade M
    Biochem Pharmacol; 2023 Jun; 212():115572. PubMed ID: 37127247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The magic and mystery of microRNA-27 in atherosclerosis.
    Chen WJ; Yin K; Zhao GJ; Fu YC; Tang CK
    Atherosclerosis; 2012 Jun; 222(2):314-23. PubMed ID: 22307089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs in atherosclerosis.
    Chen KC; Juo SH
    Kaohsiung J Med Sci; 2012 Dec; 28(12):631-40. PubMed ID: 23217354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The salient role of microRNAs in atherogenesis.
    Donaldson CJ; Lao KH; Zeng L
    J Mol Cell Cardiol; 2018 Sep; 122():98-113. PubMed ID: 30098321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Foam Cells as Therapeutic Targets in Atherosclerosis with a Focus on the Regulatory Roles of Non-Coding RNAs.
    Javadifar A; Rastgoo S; Banach M; Jamialahmadi T; Johnston TP; Sahebkar A
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33802600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs and Noncoding RNAs in Hepatic Lipid and Lipoprotein Metabolism: Potential Therapeutic Targets of Metabolic Disorders.
    Sud N; Taher J; Su Q
    Drug Dev Res; 2015 Sep; 76(6):318-27. PubMed ID: 26286650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokines, macrophage lipid metabolism and foam cells: implications for cardiovascular disease therapy.
    McLaren JE; Michael DR; Ashlin TG; Ramji DP
    Prog Lipid Res; 2011 Oct; 50(4):331-47. PubMed ID: 21601592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice.
    Sukhanov S; Higashi Y; Shai SY; Vaughn C; Mohler J; Li Y; Song YH; Titterington J; Delafontaine P
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2684-90. PubMed ID: 17916769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. microRNA-222 controls neovascularization by regulating signal transducer and activator of transcription 5A expression.
    Dentelli P; Rosso A; Orso F; Olgasi C; Taverna D; Brizzi MF
    Arterioscler Thromb Vasc Biol; 2010 Aug; 30(8):1562-8. PubMed ID: 20489169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.